Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""COVID-19 Vaccines"" wg kryterium: Temat


Tytuł :
The Nanoparticle-Enabled Success of COVID-19 mRNA Vaccines and the Promise of Microneedle Platforms for Pandemic Vaccine Response.
Autorzy :
Kapnick SM; Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
Pokaż więcej
Źródło :
DNA and cell biology [DNA Cell Biol] 2022 Jan; Vol. 41 (1), pp. 25-29. Date of Electronic Publication: 2021 Dec 24.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
COVID-19 Vaccines*
Czasopismo naukowe
Tytuł :
Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study.
Autorzy :
Esquivel-Valerio JA; Rheumatology Service, University Hospital 'Dr. Jose Eleuterio Gonzalez', Universidad Autónoma de Nuevo León, Av. Gonzalitos y Av. Madero s/n, Colonia Mitras Centro, C.P. 64460, Monterrey, NL, Mexico. .
Skinner-Taylor CM; Rheumatology Service, University Hospital 'Dr. Jose Eleuterio Gonzalez', Universidad Autónoma de Nuevo León, Av. Gonzalitos y Av. Madero s/n, Colonia Mitras Centro, C.P. 64460, Monterrey, NL, Mexico.
Moreno-Arquieta IA; Rheumatology Service, University Hospital 'Dr. Jose Eleuterio Gonzalez', Universidad Autónoma de Nuevo León, Av. Gonzalitos y Av. Madero s/n, Colonia Mitras Centro, C.P. 64460, Monterrey, NL, Mexico.
Cardenas-de la Garza JA; Rheumatology Service, University Hospital 'Dr. Jose Eleuterio Gonzalez', Universidad Autónoma de Nuevo León, Av. Gonzalitos y Av. Madero s/n, Colonia Mitras Centro, C.P. 64460, Monterrey, NL, Mexico.
Garcia-Arellano G; Rheumatology Service, University Hospital 'Dr. Jose Eleuterio Gonzalez', Universidad Autónoma de Nuevo León, Av. Gonzalitos y Av. Madero s/n, Colonia Mitras Centro, C.P. 64460, Monterrey, NL, Mexico.
Gonzalez-Garcia PL; Rheumatology Service, University Hospital 'Dr. Jose Eleuterio Gonzalez', Universidad Autónoma de Nuevo León, Av. Gonzalitos y Av. Madero s/n, Colonia Mitras Centro, C.P. 64460, Monterrey, NL, Mexico.
Almaraz-Juarez FDR; Rheumatology Service, University Hospital 'Dr. Jose Eleuterio Gonzalez', Universidad Autónoma de Nuevo León, Av. Gonzalitos y Av. Madero s/n, Colonia Mitras Centro, C.P. 64460, Monterrey, NL, Mexico.
Galarza-Delgado DA; Rheumatology Service, University Hospital 'Dr. Jose Eleuterio Gonzalez', Universidad Autónoma de Nuevo León, Av. Gonzalitos y Av. Madero s/n, Colonia Mitras Centro, C.P. 64460, Monterrey, NL, Mexico.
Pokaż więcej
Źródło :
Rheumatology international [Rheumatol Int] 2021 Dec; Vol. 41 (12), pp. 2105-2108. Date of Electronic Publication: 2021 Oct 07.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
COVID-19 Vaccines/*adverse effects
Rheumatic Diseases/*immunology
Vaccination/*statistics & numerical data
COVID-19/epidemiology ; COVID-19/immunology ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/immunology ; Cross-Sectional Studies ; Female ; Humans ; Male ; Mexico/epidemiology ; Middle Aged ; Pandemics ; Rheumatic Diseases/complications ; Rheumatology ; SARS-CoV-2 ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis.
Autorzy :
Tran S; Departments of Oncology and Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. Electronic address: .
Truong TH; Divisions of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Alberta Children's Hospital, Calgary, Alberta, Canada.
Narendran A; Departments of Oncology and Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Divisions of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Alberta Children's Hospital, Calgary, Alberta, Canada.
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Dec; Vol. 159, pp. 259-274. Date of Electronic Publication: 2021 Oct 25.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immunogenicity, Vaccine*
Vaccination*/adverse effects
Vaccine Efficacy*
COVID-19/*prevention & control
COVID-19 Vaccines/*administration & dosage
Neoplasms/*therapy
SARS-CoV-2/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Viral/blood ; COVID-19/immunology ; COVID-19/virology ; COVID-19 Vaccines/adverse effects ; COVID-19 Vaccines/immunology ; Female ; Humans ; Male ; Middle Aged ; Neoplasms/diagnosis ; Neoplasms/immunology ; Risk Factors ; SARS-CoV-2/pathogenicity ; Seroconversion ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system.
Autorzy :
Chapin-Bardales J; CDC COVID-19 Response Team, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30329, USA.
Myers T; CDC COVID-19 Response Team, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30329, USA.
Gee J; CDC COVID-19 Response Team, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30329, USA. Electronic address: .
Shay DK; CDC COVID-19 Response Team, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30329, USA.
Marquez P; CDC COVID-19 Response Team, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30329, USA.
Baggs J; CDC COVID-19 Response Team, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30329, USA.
Zhang B; CDC COVID-19 Response Team, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30329, USA.
Licata C; CDC COVID-19 Response Team, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30329, USA.
Shimabukuro TT; CDC COVID-19 Response Team, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30329, USA.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Nov 26; Vol. 39 (48), pp. 7066-7073. Date of Electronic Publication: 2021 Oct 16.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
COVID-19 Vaccines*
BNT162 Vaccine ; Centers for Disease Control and Prevention, U.S. ; Female ; Humans ; RNA, Messenger ; SARS-CoV-2 ; United States
Czasopismo naukowe
Tytuł :
COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations.
Autorzy :
Duly K; Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA.
Farraye FA; Inflammatory Bowel Disease Center, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
Bhat S; Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA.; Department of Gastroenterology, Hepatology & Nutrition, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.
Pokaż więcej
Źródło :
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2022 Jan 05; Vol. 79 (2), pp. 63-71.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19 Vaccines*
Immunocompromised Host*
COVID-19 ; Clinical Trials, Phase III as Topic ; HIV Infections ; Humans ; Retrospective Studies ; SARS-CoV-2 ; Vaccination Hesitancy
Czasopismo naukowe
Tytuł :
Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in mice.
Autorzy :
Song S; Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, Guangdong Province, China.; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
Zhou B; Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, Guangdong Province, China.; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
Cheng L; Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, Guangdong Province, China.; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
Liu W; Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, Guangdong Province, China.; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
Fan Q; Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, Guangdong Province, China.; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
Ge X; Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, Guangdong Province, China.; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
Peng H; Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.; Guangzhou Laboratory, and Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, China.
Fu YX; Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, China. .
Ju B; Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, Guangdong Province, China. .; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong Province, China. .; Guangdong Key Laboratory for Anti-Infection Drug Quality Evaluation, Shenzhen, Guangdong Province, China. .
Zhang Z; Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, Guangdong Province, China. .; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong Province, China. .; Shenzhen Research Center for Communicable Disease Diagnosis and Treatment of Chinese Academy of Medical Science, Shenzhen, Guangdong Province, China. .; Guangdong Key Laboratory for Anti-Infection Drug Quality Evaluation, Shenzhen, Guangdong Province, China. .
Pokaż więcej
Źródło :
Virology journal [Virol J] 2022 Jan 04; Vol. 19 (1), pp. 2. Date of Electronic Publication: 2022 Jan 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*/immunology
COVID-19*/prevention & control
COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/immunology
SARS-CoV-2*/immunology
Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Mice
SCR Organism :
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł :
Do health-care workers need a COVID-19 vaccine booster?
Autorzy :
Cirillo N; Melbourne Dental School, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC 3053, Australia. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Jan; Vol. 22 (1), pp. 20.
Typ publikacji :
Letter
MeSH Terms :
COVID-19/*prevention & control
COVID-19 Vaccines/*standards
Health Personnel/*statistics & numerical data
Immunization, Secondary/*standards
Adult ; Aged ; BNT162 Vaccine/immunology ; COVID-19/immunology ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/immunology ; Global Health ; Humans ; Middle Aged ; SARS-CoV-2/immunology ; Vaccination/legislation & jurisprudence ; Vaccination/standards
SCR Protocol :
COVID-19 vaccine booster shot
Opinia redakcyjna
Tytuł :
Intradermal immunization-a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines?
Autorzy :
Schnyder JL; Centre for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Amsterdam UMC, Amsterdam Infection & Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, the Netherlands.
de Jong HK; Centre for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Amsterdam UMC, Amsterdam Infection & Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, the Netherlands.
Grobusch MP; Centre for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Amsterdam UMC, Amsterdam Infection & Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, the Netherlands; Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany; Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Centre de Recherches Médicales en Lambaréné (CERMEL), Lambaréné, Gabon; Masanga Medical Research Unit (MMRU), Masanga, Sierra Leone. Electronic address: .
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2022 Jan; Vol. 28 (1), pp. 6-8. Date of Electronic Publication: 2021 Aug 29.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*/prevention & control
COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/supply & distribution
Injections, Intradermal*
Vaccination/*methods
Adaptive Immunity ; Antigen-Presenting Cells/immunology ; Humans ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
[ F]FDG uptake of axillary lymph nodes after COVID-19 vaccination in oncological PET/CT: frequency, intensity, and potential clinical impact.
Autorzy :
Skawran S; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Gennari AG; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Dittli M; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Treyer V; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Muehlematter UJ; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Maurer A; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Burger IA; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.; Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland.
Mader C; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Messerli O; University of Zurich, Zurich, Switzerland.; Department of Dermatology, University Hospital Zurich, Zürich, Switzerland.
Grünig H; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Gebhard C; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Huellner MW; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Curioni-Fontecedro A; University of Zurich, Zurich, Switzerland.; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
Berger C; University of Zurich, Zurich, Switzerland.; Division of Infectious Diseases and Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland.
Messerli M; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland. .; University of Zurich, Zurich, Switzerland. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2022 Jan; Vol. 32 (1), pp. 508-516. Date of Electronic Publication: 2021 Jun 22.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
COVID-19 Vaccines*
2019-nCoV Vaccine mRNA-1273 ; BNT162 Vaccine ; Fluorodeoxyglucose F18 ; Humans ; Lymph Nodes/diagnostic imaging ; Positron Emission Tomography Computed Tomography ; Retrospective Studies ; SARS-CoV-2 ; Vaccination
Czasopismo naukowe
Tytuł :
Omicron sparks a vaccine strategy debate.
Autorzy :
Cohen J
Pokaż więcej
Źródło :
Science (New York, N.Y.) [Science] 2021 Dec 24; Vol. 374 (6575), pp. 1544-1545. Date of Electronic Publication: 2021 Dec 23.
Typ publikacji :
Wiadomości
MeSH Terms :
COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/immunology
Immunization, Secondary*
COVID-19/*prevention & control
SARS-CoV-2/*immunology
COVID-19/immunology ; COVID-19/virology ; Coronavirus/immunology ; Humans ; Immunogenicity, Vaccine ; Vaccine Development ; Viral Vaccines
SCR Protocol :
COVID-19 vaccine booster shot
Periodyk
Tytuł :
A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques.
Autorzy :
O'Connor MA; Department of Microbiology, University of Washington, Seattle, WA, United States.; Washington National Primate Research Center, University of Washington, Seattle, WA, United States.
Erasmus JH; Department of Microbiology, University of Washington, Seattle, WA, United States.; HDT Bio, Seattle, WA, United States.
Randall S; Department of Microbiology, University of Washington, Seattle, WA, United States.
Archer J; Department of Microbiology, University of Washington, Seattle, WA, United States.; HDT Bio, Seattle, WA, United States.
Lewis TB; Department of Microbiology, University of Washington, Seattle, WA, United States.; Washington National Primate Research Center, University of Washington, Seattle, WA, United States.
Brown B; Department of Microbiology, University of Washington, Seattle, WA, United States.; Washington National Primate Research Center, University of Washington, Seattle, WA, United States.
Fredericks M; Department of Microbiology, University of Washington, Seattle, WA, United States.; Washington National Primate Research Center, University of Washington, Seattle, WA, United States.
Groenier S; Department of Microbiology, University of Washington, Seattle, WA, United States.
Iwayama N; Washington National Primate Research Center, University of Washington, Seattle, WA, United States.
Ahrens C; Washington National Primate Research Center, University of Washington, Seattle, WA, United States.
Garrison W; Washington National Primate Research Center, University of Washington, Seattle, WA, United States.
Wangari S; Washington National Primate Research Center, University of Washington, Seattle, WA, United States.
Guerriero KA; Washington National Primate Research Center, University of Washington, Seattle, WA, United States.
Fuller DH; Department of Microbiology, University of Washington, Seattle, WA, United States.; Washington National Primate Research Center, University of Washington, Seattle, WA, United States.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Dec 21; Vol. 12, pp. 800723. Date of Electronic Publication: 2021 Dec 21 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Immunogenicity, Vaccine*
Vaccine Efficacy*
COVID-19/*prevention & control
COVID-19 Vaccines/*administration & dosage
Immunity, Cellular/*drug effects
Immunity, Humoral/*drug effects
Simian Acquired Immunodeficiency Syndrome/*immunology
Simian Immunodeficiency Virus/*immunology
Spike Glycoprotein, Coronavirus/*administration & dosage
mRNA Vaccines/*administration & dosage
Animals ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; COVID-19/immunology ; COVID-19/virology ; COVID-19 Vaccines/genetics ; COVID-19 Vaccines/immunology ; Cells, Cultured ; Disease Models, Animal ; Host-Pathogen Interactions ; Immunocompromised Host ; Macaca nemestrina ; Male ; Simian Acquired Immunodeficiency Syndrome/blood ; Simian Acquired Immunodeficiency Syndrome/virology ; Simian Immunodeficiency Virus/pathogenicity ; Spike Glycoprotein, Coronavirus/genetics ; Spike Glycoprotein, Coronavirus/immunology ; Th1 Cells/drug effects ; Th1 Cells/immunology ; Th1 Cells/virology ; Time Factors ; Vaccination ; mRNA Vaccines/genetics ; mRNA Vaccines/immunology
Czasopismo naukowe
Tytuł :
COVID-19 Vaccine Acceptance of Pregnant and Lactating Women (PLW) in Czechia: An Analytical Cross-Sectional Study.
Autorzy :
Riad A; Department of Public Health, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.; Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Faculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
Jouzová A; Department of Obstetrics and Gynecology, University Hospital Brno and Medical Faculty, Masaryk University, Obilní Trh 11, 60200 Brno, Czech Republic.
Üstün B; Department of Gynecology and Obstetrics, Faculty of Medicine, Namık Kemal University, Namık Kemal Kampüs Caddesi No. 1, Merkez, Tekirdağ 59030, Turkey.
Lagová E; Department of Public Health, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
Hruban L; Department of Obstetrics and Gynecology, University Hospital Brno and Medical Faculty, Masaryk University, Obilní Trh 11, 60200 Brno, Czech Republic.
Janků P; Department of Obstetrics and Gynecology, University Hospital Brno and Medical Faculty, Masaryk University, Obilní Trh 11, 60200 Brno, Czech Republic.; Department of Health Sciences, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
Pokorná A; Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Faculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.; Department of Health Sciences, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
Klugarová J; Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Faculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.; Department of Health Sciences, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
Koščík M; Department of Public Health, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
Klugar M; Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Faculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.; Department of Health Sciences, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Dec 19; Vol. 18 (24). Date of Electronic Publication: 2021 Dec 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*
COVID-19 Vaccines*
Child ; Cross-Sectional Studies ; Czech Republic ; Female ; Humans ; Lactation ; Pregnancy ; Pregnant Women ; SARS-CoV-2 ; Vaccination ; Vaccination Hesitancy ; Vaccine Efficacy
Czasopismo naukowe
Tytuł :
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Autorzy :
Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: .
Minassian AM; The Jenner Institute, University of Oxford, Oxford, UK.
Ewer KJ; The Jenner Institute, University of Oxford, Oxford, UK.
Flaxman AL; The Jenner Institute, University of Oxford, Oxford, UK.
Folegatti PM; The Jenner Institute, University of Oxford, Oxford, UK.
Owens DR; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Angus B; The Jenner Institute, University of Oxford, Oxford, UK.
Babbage G; The Jenner Institute, University of Oxford, Oxford, UK.
Belij-Rammerstorfer S; The Jenner Institute, University of Oxford, Oxford, UK.
Berry L; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Bittaye M; The Jenner Institute, University of Oxford, Oxford, UK.
Cathie K; Paediatric Medicine, University of Southampton, Southampton, UK.
Chappell H; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Charlton S; National Infection Service, Public Health England, Porton Down, Salisbury, UK.
Cicconi P; The Jenner Institute, University of Oxford, Oxford, UK.
Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Colin-Jones R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Fedosyuk S; The Jenner Institute, University of Oxford, Oxford, UK.
Fuskova M; The Jenner Institute, University of Oxford, Oxford, UK.
Gbesemete D; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Green C; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK.
Hallis B; National Infection Service, Public Health England, Porton Down, Salisbury, UK.
Hou MM; The Jenner Institute, University of Oxford, Oxford, UK.
Jenkin D; The Jenner Institute, University of Oxford, Oxford, UK.
Joe CCD; The Jenner Institute, University of Oxford, Oxford, UK.
Kelly EJ; AstraZeneca BioPharmaceuticals Research and Development, Washington, DC, USA.
Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Lawrie AM; The Jenner Institute, University of Oxford, Oxford, UK.
Lelliott A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Lwin MN; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Makinson R; The Jenner Institute, University of Oxford, Oxford, UK.
Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Mujadidi Y; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Munro APS; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Pacurar M; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Rand J; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Rawlinson T; The Jenner Institute, University of Oxford, Oxford, UK.
Rhead S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Robinson H; Nuffield Department of Medicine, and Oxford Centre for Clinical Tropical Medicine and Global Health, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Ritchie AJ; The Jenner Institute, University of Oxford, Oxford, UK.
Ross-Russell AL; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Saich S; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Singh N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Smith CC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
Tarrant R; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK.
Themistocleous Y; The Jenner Institute, University of Oxford, Oxford, UK.
Thomas KM; National Infection Service, Public Health England, Porton Down, Salisbury, UK.
Villafana TL; AstraZeneca BioPharmaceuticals Research and Development, Bethesda, MA, USA.
Warren SC; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Watson MEE; The Jenner Institute, University of Oxford, Oxford, UK.
Douglas AD; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Hill AVS; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Lambe T; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Gilbert SC; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Trust and Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Pokaż więcej
Corporate Authors :
Oxford COVID Vaccine Trial Group
Źródło :
Lancet (London, England) [Lancet] 2021 Dec 19; Vol. 396 (10267), pp. 1979-1993. Date of Electronic Publication: 2020 Nov 19.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunogenicity, Vaccine*
COVID-19 Vaccines/*administration & dosage
Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; COVID-19/prevention & control ; COVID-19 Vaccines/adverse effects ; COVID-19 Vaccines/pharmacology ; ChAdOx1 nCoV-19 ; Female ; Humans ; Immunization, Secondary/adverse effects ; Immunoglobulin G/blood ; Immunoglobulin G/drug effects ; Male ; Middle Aged ; SARS-CoV-2/drug effects ; Single-Blind Method ; Young Adult
Czasopismo naukowe
Tytuł :
Missed shots.
Autorzy :
Kupferschmidt K
Pokaż więcej
Źródło :
Science (New York, N.Y.) [Science] 2021 Dec 17; Vol. 374 (6574), pp. 1434-1435. Date of Electronic Publication: 2021 Dec 16.
Typ publikacji :
Wiadomości
MeSH Terms :
COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/immunology
COVID-19 Vaccines*/supply & distribution
COVID-19/*prevention & control
COVID-19/epidemiology ; COVID-19/immunology ; COVID-19/virology ; Humans ; Immunization, Secondary ; Vaccination Coverage ; Vaccination Hesitancy
SCR Protocol :
COVID-19 vaccine booster shot
Periodyk
Tytuł :
COVID-19 impact on infant and adolescent vaccine supplies.
Autorzy :
Cernuschi T; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Malvolti S; MMGH Consulting GmbH, Zurich, Switzerland.
Downham M; Coalition for Epidemic Preparedness Innovations, London, UK.
Maugeais D; Gavi, the Vaccine Alliance, Geneva, Switzerland.
Robinson D; Bill & Melinda Gates Foundation, Seattle, WA, USA.
Cravioto A; Faculty of Medicine, Universidad Nacional Autonóma de México, Mexico City, Mexico.
Pokaż więcej
Źródło :
Science (New York, N.Y.) [Science] 2021 Dec 17; Vol. 374 (6574), pp. 1438-1441. Date of Electronic Publication: 2021 Dec 16.
Typ publikacji :
Journal Article
MeSH Terms :
Bacterial Vaccines/*supply & distribution
COVID-19/*epidemiology
COVID-19 Vaccines/*supply & distribution
Vaccine-Preventable Diseases/*prevention & control
Viral Vaccines/*supply & distribution
Adolescent ; Bacterial Vaccines/economics ; Bacterial Vaccines/standards ; COVID-19/prevention & control ; COVID-19 Vaccines/economics ; COVID-19 Vaccines/standards ; Humans ; Infant ; Quality Control ; Viral Vaccines/economics ; Viral Vaccines/standards
Czasopismo naukowe
Tytuł :
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.
Autorzy :
Elliott P; School of Public Health, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.; National Institute for Health Research Imperial Biomedical Research Centre, London, UK.; MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.; Health Data Research UK London at Imperial College London, London, UK.; UK Dementia Research Institute Centre at Imperial, London, UK.
Haw D; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis and Jameel Institute, Imperial College London, London, UK.
Wang H; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis and Jameel Institute, Imperial College London, London, UK.
Eales O; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis and Jameel Institute, Imperial College London, London, UK.
Walters CE; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis and Jameel Institute, Imperial College London, London, UK.
Ainslie KEC; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis and Jameel Institute, Imperial College London, London, UK.; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Atchison C; School of Public Health, Imperial College London, London, UK.
Fronterre C; CHICAS, Lancaster Medical School, Lancaster University, and Health Data Research UK, Lancaster, UK.
Diggle PJ; CHICAS, Lancaster Medical School, Lancaster University, and Health Data Research UK, Lancaster, UK.
Page AJ; Quadram Institute, Norwich, UK.
Trotter AJ; Quadram Institute, Norwich, UK.
Prosolek SJ; Quadram Institute, Norwich, UK.
Ashby D; School of Public Health, Imperial College London, London, UK.
Donnelly CA; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis and Jameel Institute, Imperial College London, London, UK.; Department of Statistics, University of Oxford, Oxford, UK.
Barclay W; Department of Infectious Disease, Imperial College London, London, UK.
Taylor G; Department of Infectious Disease, Imperial College London, London, UK.
Cooke G; Imperial College Healthcare NHS Trust, London, UK.; National Institute for Health Research Imperial Biomedical Research Centre, London, UK.; Department of Infectious Disease, Imperial College London, London, UK.
Ward H; School of Public Health, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.; National Institute for Health Research Imperial Biomedical Research Centre, London, UK.
Darzi A; Imperial College Healthcare NHS Trust, London, UK.; National Institute for Health Research Imperial Biomedical Research Centre, London, UK.; Institute of Global Health Innovation at Imperial College London, London, UK.; Health Security Initiative, Flagship Pioneering UK Ltd., Bristol, UK.
Riley S; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis and Jameel Institute, Imperial College London, London, UK.
Pokaż więcej
Corporate Authors :
COVID-19 Genomics UK (COG-UK) Consortium11‡
Źródło :
Science (New York, N.Y.) [Science] 2021 Dec 17; Vol. 374 (6574), pp. eabl9551. Date of Electronic Publication: 2021 Dec 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/immunology
SARS-CoV-2*
Vaccine Efficacy*
COVID-19/*epidemiology
COVID-19/*virology
Adolescent ; Adult ; Age Factors ; Aged ; COVID-19/diagnosis ; COVID-19/prevention & control ; COVID-19 Nucleic Acid Testing ; Child ; Child, Preschool ; England/epidemiology ; Ethnicity ; Family Characteristics ; Female ; Hospitalization ; Humans ; Male ; Middle Aged ; Prevalence ; Self Report ; Socioeconomic Factors ; Vaccination Coverage ; Young Adult
SCR Organism :
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł :
Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice.
Autorzy :
Lin HT; Institute of Preventive Medicine, National Defense Medical Center, New Taipei City 23742, Taiwan, ROC.
Chen CC; Institute of Preventive Medicine, National Defense Medical Center, New Taipei City 23742, Taiwan, ROC; Graduate Institute of Medical Science, National Defense Medical Center, Taipei 11490, Taiwan, ROC.
Chiao DJ; Institute of Preventive Medicine, National Defense Medical Center, New Taipei City 23742, Taiwan, ROC.
Chang TY; Institute of Preventive Medicine, National Defense Medical Center, New Taipei City 23742, Taiwan, ROC.
Chen XA; Institute of Preventive Medicine, National Defense Medical Center, New Taipei City 23742, Taiwan, ROC.
Young JJ; Institute of Preventive Medicine, National Defense Medical Center, New Taipei City 23742, Taiwan, ROC. Electronic address: .
Kuo SC; Institute of Preventive Medicine, National Defense Medical Center, New Taipei City 23742, Taiwan, ROC; Department and Graduate Institute of Microbiology and Immunology, National Defense Medical Center, Taipei 11490, Taiwan, ROC. Electronic address: .
Pokaż więcej
Źródło :
International journal of biological macromolecules [Int J Biol Macromol] 2021 Dec 15; Vol. 193 (Pt B), pp. 1885-1897. Date of Electronic Publication: 2021 Nov 11.
Typ publikacji :
Journal Article
MeSH Terms :
Adjuvants, Immunologic*/chemistry
Adjuvants, Immunologic*/pharmacology
COVID-19 Vaccines*/chemistry
COVID-19 Vaccines*/pharmacology
Immunogenicity, Vaccine*
Nanoparticles*/chemistry
Nanoparticles*/therapeutic use
Oligodeoxyribonucleotides*/chemistry
Oligodeoxyribonucleotides*/pharmacology
Spike Glycoprotein, Coronavirus*/chemistry
Spike Glycoprotein, Coronavirus*/pharmacology
Antibodies, Viral/*immunology
Broadly Neutralizing Antibodies/*immunology
SARS-CoV-2/*immunology
Th1 Cells/*immunology
Animals ; Mice ; Mice, Inbred BALB C
Czasopismo naukowe
Tytuł :
Immunology and controlling of coronaviruses; the current enemy for humanity: A review.
Autorzy :
Othman SI; Biology Department, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. Electronic address: .
Nayel MA; Department of Animal Medicine and Infectious Diseases, Faculty of Veterinary Medicine, University of Sadat City, Sadat City 32897, Menoufia, Egypt.
Alwaele MA; Biology Department, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Al Fassam H; Biology Department, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Abu-Taweel GM; Department of Biology, College of Science, Jazan University, P.O. Box 2079, Jazan 45142, Saudi Arabia.
Altoom NG; Department of Biology, King Khalid Military Academy, Riyadh 14625, Saudi Arabia.
Almalki AM; Zoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Allam AA; Department of Zoology, Faculty of Science, Beni-suef University, Beni-suef 65211, Egypt. Electronic address: .
Alturki AM; Department of Chemistry, Faculty of Science, University of Tabuk, Saudi Arabia.
El-Shabasy RM; Department of Chemistry, Faculty of Science, Menoufia University, 32512 Shebin El-Kom, Egypt. Electronic address: .
Pokaż więcej
Źródło :
International journal of biological macromolecules [Int J Biol Macromol] 2021 Dec 15; Vol. 193 (Pt B), pp. 1532-1540. Date of Electronic Publication: 2021 Oct 31.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19*/immunology
COVID-19*/mortality
COVID-19*/prevention & control
COVID-19 Vaccines*/immunology
COVID-19 Vaccines*/therapeutic use
Immunologic Memory*
Host-Pathogen Interactions/*immunology
SARS-CoV-2/*physiology
Humans
Czasopismo naukowe
Tytuł :
Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials.
Autorzy :
Joffe S; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Babiker A; Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom.
Ellenberg SS; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Fix A; Center for Vaccine Innovation and Access, PATH, Washington, District of Columbia, USA.
Griffin MR; Vanderbilt School of Medicine, Nashville, Tennessee, USA.
Hunsberger S; National Institute of Allergy and Infectious Disease, Rockville, Maryland, USA.
Kalil J; Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Levine MM; University of Maryland School of Medicine, Baltimore, Maryland, USA.
Makgoba MW; Health Ombudsman, Office of Health Standards and Compliance, Pretoria, Republic of South Africa.
Moore RH; Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Tsiatis AA; North Carolina State University, Raleigh, North Carolina, USA.
Whitley R; University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2021 Dec 15; Vol. 224 (12), pp. 1995-2000.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
COVID-19/*prevention & control
COVID-19 Vaccines/*adverse effects
COVID-19 Vaccines/*immunology
Aged ; COVID-19 Vaccines/administration & dosage ; Humans ; SARS-CoV-2 ; United States ; Vaccines
Czasopismo naukowe
Tytuł :
A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters.
Autorzy :
Liu X; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Luongo C; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Matsuoka Y; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Park HS; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Santos C; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Yang L; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Moore IN; Infectious Disease and Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Afroz S; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Johnson RF; SARS-CoV-2 Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Lafont BAP; SARS-CoV-2 Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Martens C; Research Technologies Section, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840.
Best SM; Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840.
Munster VJ; Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840.
Hollý J; Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Yewdell JW; Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Le Nouën C; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; .
Munir S; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; .
Buchholz UJ; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; .
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Dec 14; Vol. 118 (50).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms :
COVID-19/*prevention & control
COVID-19 Vaccines/*administration & dosage
SARS-CoV-2/*immunology
Administration, Intranasal ; Animals ; Antibodies, Viral/blood ; COVID-19 Vaccines/genetics ; COVID-19 Vaccines/immunology ; Cricetinae ; Genetic Vectors ; Immunization ; Parainfluenza Virus 3, Bovine/genetics ; Parainfluenza Virus 3, Human/genetics ; Spike Glycoprotein, Coronavirus/genetics ; Spike Glycoprotein, Coronavirus/immunology ; Vaccines, Attenuated/administration & dosage ; Vaccines, Attenuated/genetics ; Vaccines, Attenuated/immunology ; Vaccines, Synthetic/administration & dosage ; Vaccines, Synthetic/genetics ; Vaccines, Synthetic/immunology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies